Showing results (71-80 of 160) with videos related to
Sort By:
Pageof 16
Journal of Gastrointestinal Cancer|February 2, 2012
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research studyEfrat Dotan, Neal J Meropol, Barbara Burtness, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosisEirini Pectasides, Ann-Marie Egloff, Clarence Sasaki, et al.Oral Oncology|September 24, 2013
Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongueDennis M Sopka, Tianyu Li, Miriam N Lango, et al.Viruses|December 23, 2023
Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping ReviewTaja Lozar, Wei Wang, Niki Gavrielatou, et al.Human Genetics|August 11, 2014
Predicting survival in head and neck squamous cell carcinoma from TP53 mutationDavid L Masica, Shuli Li, Christopher Douville, et al.Annals of Surgical Oncology|September 28, 2011
Significance of pathologic response to preoperative therapy in pancreatic cancerYun Shin Chun, Harry S Cooper, Steven J Cohen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 26, 2020
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancerKenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 28, 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancerBarbara Burtness, Milan Anadkat, Surendra Basti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2017
Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck CancerAsel Biktasova, Michael Hajek, Andrew Sewell, et al.Oral Oncology|March 31, 2018
Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancerJacqueline R Kelly, Henry S Park, Yi An, et al.Pageof 16